Preclinical studies show that IGF-1R activation suppresses HIF-1 signaling, reducing metabolic dysfunction, hepatic steatosis, and inflammation in high-fat diet-fed mice (Zheng et al., 2021). This evidence concerns the gene IGF1R and Hepatic steatosis.